Company page

Novo Nordisk A/s Class B

Novo Nordisk A/S Class B is a leading public company based in Denmark, specializing in diabetes care and hormone replacement therapies. With a substantial market capitalization of approximately 202.89 billion DKK, the company is a key player in the global healthcare sector. Novo Nordisk is committed to innovation and improving patient outcomes through its diverse range of pharmaceutical products.